Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Protein interaction networks revealed by proteome coevolution
2019 StandoutScienceNobel
Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHs
2018
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
2019 StandoutScienceNobel
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
A Chemically Defined Trifunctional Antibody–Cytokine–Drug Conjugate with Potent Antitumor Activity
2014
Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study
2023
Features, Evaluation and Treatment Coronavirus (COVID-19)
2020 Standout
Cytokines in the Treatment of Cancer
2018
Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review
2023
Treg-based immunotherapy for antigen-specific immune suppression and stable tolerance induction: a perspective
2023 StandoutNobel
Regulatory T cells in autoimmune kidney diseases and transplantation
2023 StandoutNobel
The challenges and molecular approaches surrounding interleukin-2-based therapeutics in cancer
2018
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
A mosquito AgTRIO mRNA vaccine contributes to immunity against malaria
2023 StandoutNobel
A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control
2019
Engineered receptors for soluble cellular communication and disease sensing
2024 StandoutNatureNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
2017
Delivering safer immunotherapies for cancer
2017
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Long COVID: major findings, mechanisms and recommendations
2023 Standout
Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity
2017
Enhancing extracellular vesicle cargo loading and functional delivery by engineering protein-lipid interactions
2024 StandoutNobel
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
d-Galactose-induced accelerated aging model: an overview
2019 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms
2015
Mouse cytomegalovirus-experienced ILC1s acquire a memory response dependent on the viral glycoprotein m12
2019
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases
2015
Multifarious Determinants of Cytokine Receptor Signaling Specificity
2014
Macrophages in immunoregulation and therapeutics
2023 Standout
Interleukin-2 Activity Can Be Fine Tuned with Engineered Receptor Signaling Clamps
2015
Control of Germinal Center Responses by T-Follicular Regulatory Cells
2018 StandoutNobel
Dynamic regulation of T follicular regulatory cell responses by interleukin 2 during influenza infection
2017
Recent advances in understanding the role of IL-4 signaling
2021
Natural killer cells and other innate lymphoid cells in cancer
2018
Engineering interferons and interleukins for cancer immunotherapy
2022
Delivery technologies for cancer immunotherapy
2019 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism
2018
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Foxp3: a genetic foundation for regulatory T cell differentiation and function
2020 StandoutNobel
Th1 cytokine-based immunotherapy for cancer
2014
The advent of de novo proteins for cancer immunotherapy
2020
Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
2013
The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity
2017 StandoutNobel
Control of Metastasis by NK Cells
2017
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8+ T cells to overcome immunotherapy resistance in cancer
2022
Role of IL-2 in cancer immunotherapy
2016
Modulation of EZH2 expression in T cells improves efficacy of anti–CTLA-4 therapy
2018 StandoutNobel
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2
2022
Cytokines in Cancer Immunotherapy
2017
Surrogate Wnt agonists that phenocopy canonical Wnt and β-catenin signalling
2017 StandoutNatureNobel
Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells
2020 StandoutNobel
Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure)
2016
Defining trained immunity and its role in health and disease
2020 Standout
Antibody-cytokine fusion proteins: A novel class of biopharmaceuticals for the therapy of cancer and of chronic inflammation
2019
New Treg cell-based therapies of autoimmune diseases: towards antigen-specific immune suppression
2020 StandoutNobel
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Receptor subtype discrimination using extensive shape complementary designed interfaces
2019 StandoutNobel
Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity
2020
Treg cell-based therapies: challenges and perspectives
2019
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Modular design of synthetic receptors for programmed gene regulation in cell therapies
2022
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy
2020
Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease Therapy
2018
Regulatory T Cells and Human Disease
2020 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Insights into Cytokine–Receptor Interactions from Cytokine Engineering
2014
Yulangsan polysaccharide improves redox homeostasis and immune impairment in d -galactose-induced mimetic aging
2015
Computational Evolution of Threonine-Rich β-Hairpin Peptides Mimicking Specificity and Affinity of Antibodies
2019 StandoutNobel
Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2
2016
Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2
2013
Control of foreign Ag‐specific Ab responses by Treg and Tfr
2020 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Targeting an engineered cytokine with interleukin-2 and interleukin-15 activity to the neovasculature of solid tumors
2020
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment
2022
An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice
2020
Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts
2020
Regulatory roles of IL-10–producing human follicular T cells
2019 StandoutNobel
Effects of interleukin-2 in immunostimulation and immunosuppression
2019
Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold
2022 StandoutNobel
Synthetic cytokine circuits that drive T cells into immune-excluded tumors
2022 Science
Predicting protein–protein interactions through sequence-based deep learning
2018
Synthetic Nanoparticles for Vaccines and Immunotherapy
2015
Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy
2020 StandoutNobel
Works of Miro E. Raeber being referenced
Rapid expansion of Treg cells protects from collateral colitis following a viral trigger
2020
Signature of long-lived memory CD8+ T cells in acute SARS-CoV-2 infection
2021 Nature
Use of enhanced interleukin-2 formulations for improved immunotherapy against cancer
2014
A distinct innate immune signature marks progression from mild to severe COVID-19
2020
Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’
2012 Nature
Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome
2022
IL-4 receptor engagement in human neutrophils impairs their migration and extracellular trap formation
2019
The role of cytokines in T‐cell memory in health and disease
2018